In these states, an experienced PMHNP could prescribe GLP-1s or other weight-loss medications on their own, provided: Examples of FPA states (as of 2026): Arizona, Colorado, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, Washington, Wyoming, and soon California (phased in 2023-2026)
Aortic root or annular aneurysm
Retatrutide hits the glucagon receptor directly
1 H-MR spectroscopy data were acquired using a GSH-optimized MEGA-PRESS editing sequence and GSH/creatine ratios were calculated for DLPFC (SZ: n = 33, HC: n = 37) and visual cortex (SZ: n = 29, HC: n = 35) voxels
A letter from the PBM to the prescriber will then follow
Mol Metab 46:101139 Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM et al (2020) Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist